The generic drug, Etoricoxib, brand name – Arcoxia, is a selective COX-2 inhibitor approved in more than 80 countries worldwide except the US. That is because the American drug approval authorities need further safety and efficacy data before approving this drug. An anti-inflammatory and pain medication, Etoricoxib is used to treat ankylosing spondylitis, rheumatoid, psoriatic, and osteoarthritis, acute pain, chronic low back pain, and gout. InternationalDrugMart.com offers generic prescription and Over – the – Counter drugs (OTC) that cost much less than their branded counterparts.
Research points to the higher efficacy of Etoricoxib over naproxen, and placebo. The drug was steadily observed through a series of measures, including tender and swollen joint counts and assessments of pain, inflammation, and physical function. The study observed that Etoricoxib was commonly well tolerated in patients with rheumatoid arthritis. Patients in the naproxen group experienced higher incidences of dyspepsia, heartburn and nausea than patients in the Etoricoxib group.
Etroricoxib is classed as a selective COX-2 inhibitor. When compared to traditional non-steroidal anti-inflammatory drugs (NSAID), selective COX-2 inhibitors demonstrate less activity on COX-1. This reduced activity causes lesser gastrointestinal side effects shown in several large clinical trials. Etoricoxib reduces swelling and lowers fever. As it blocks the COX-2 enzymes that create prostaglandins, Etoricoxib works by chemically blocking the body from making as many prostaglandins, and reducing pain and inflammation.
Side-Effects include:
InternationalDrugmart.com understands that many Americans are unable to afford chronic pain medication on their healthcare insurance or aren’t covered at all. Buying generic prescription and OTC drugs enable older Americans to pay for their daily living expenses & stay on their medicine schedule for longer.
No comments yet.
RSS feed for comments on this post. TrackBack URL
You must be logged in to post a comment.